Skip Navigation
Skip to contents

KoreaMed

View Menu

Go to Home

Search

-Advanced Search   -Search Guidelines

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

16 results
Display

Email citations

Send Email
recaptcha 영역

Close

Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines

Lee B, Chang SJ, Kwon BS, Son JH, Lim MC, Kim YH, Lee SW, Choi CH, Eoh KJ, Lee JY, Suh DH, Kim YB

Since the latest practice guidelines for ovarian cancer were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2021, many studies have examined the efficacy and safety of various...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment

Seino M, Nagase S, Tokunaga H, Yamagami W, Kobayashi Y, Tabata T, Kaneuchi M, Hirashima Y, Niikura H, Yoshino K, Takehara K, Baba T, Katabuchi H, Mikami M

The Japan Society of Gynecologic Oncology (JSGO) Guidelines 2022 for the Treatment of Uterine Cervical Cancer are revised from the 2017 guideline. This guideline aimed to provide standard care for...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study

Chen T, Xu J, Xia B, Wang H, Shen Y

Background: Epithelial ovarian cancer is the leading cause of death among gynecological malignancies. Platinum resistance remains a dilemma and bottleneck in treatment, and salvage chemotherapy has limited effectiveness. Recently, the...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reviewer recognition in 2023

Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea

Ha HI, Kim JH, Lim J, Song YJ, Won YJ, Lim MC

Objective: To investigate the incidence and survival outcomes of ovarian carcinosarcoma in Korea between 1999 and 2018. Methods: Patients diagnosed with ovarian carcinosarcoma between 1999 and 2018 were identified from the...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer

García E, Ayoub N, Tewari KS

Cervical cancer continues to be a global threat affecting individuals in resource poor communities disproportionately. The treatment paradigm for this disease is ever evolving with recent innovations propelling oncologic outcomes...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sentinel node mapping in endometrial cancer

Bogani G, Giannini A, Vizza E, Donato VD, Raspagliesi F

Nodal status is one of the most important prognostic factors for patients with apparent early stage endometrial cancer. The role of retroperitoneal staging in endometrial cancer is controversial. Nodal status...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Identification of the prognostic immune subtype in copy-number high endometrial cancer

Mao M, Jiang F, Han R, Xiang Y

Objective: The TCGA molecular subtype of endometrial cancer (EC) is widely applied, among which the copy-number high (CNH) subtype has the poorest prognosis. However, the heterogeneity of this subtype remains...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor

Li F, Mei F, Yin S, Du Y, Hu L, Hong W, Li J

Objective: To compare the efficacy and safety of neoadjuvant chemotherapy combined with concurrent chemoradiotherapy (NACT+CCRT) vs. concurrent chemoradiotherapy (CCRT) in locally advanced cervical cancer (LACC) patients with large tumor masses. Methods:...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of survival outcomes between robotic and laparoscopic radical hysterectomies for early-stage cervical cancer: a systemic review and meta-analysis

Hwang JH, Kim B

Objective: Survival outcomes of robotic radical hysterectomy (RRH) remain controversial. Therefore, we performed a meta-analysis to evaluate survival outcomes between RRH) and laparoscopic radical hysterectomy (LRH) in patients with early-stage cervical...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Feasibility, accuracy and acceptability of self-sampled human papillomavirus testing using careHPV in Cambodia: a cross-sectional study

Hang S, Haruyama R, Uy K, Fujita N, Kimura T, Koum K, Kawana K

Objective: Self-sampled human papillomavirus (HPV) testing is a potential option for cervical cancer screening, but research is scarce in Cambodia. We evaluated the feasibility, accuracy, and acceptability of self-sampled HPV...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience

Tortorella L, Marco C, Loverro M, Carmine C, Persichetti E, Bizzarri N, Barbara C, Francesco S, Foschi N, Gallotta V, Avesani G, Chiantera V, Ercoli A, Fanfani F, Fagotti A, Mele MC, Restaino S, Alletti SG, Scambia G, Vizzielli G

Objective: To evaluate pre-operative predictors of early (
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of immediate germline sequencing and multi-step screening for Lynch syndrome detection in high-risk endometrial and colorectal cancer patients

Chao AS, Chao A, Lai CH, Lin CY, Yang LY, Chang SC, Wu RC

Objective: Lynch syndrome (LS) is a hereditary cancer predisposition syndrome with a significantly increased risk of colorectal and endometrial cancers. Current standard practice involves universal screening for LS in patients...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey

Kim JH, Lee Y, Kim DY, Kim S, Seo SS, Kang S, Park SY, Lim MC

Objective: To identify the adherence rate to poly (ADP-ribose) polymerase (PARP) inhibitors and identify factors contributing to the deterioration of adherence at our institution. Methods: The adherence rate to PARP inhibitors...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Olaparib plus bevacizumab as a first-line maintenance treatment for patients with advanced ovarian cancer by molecular status: an updated PAOLA-1 based cost-effectiveness analysis

Zhu Y, Yang Q, Liu K, Cao H, Zhu H

Objective: The PAOLA-1 trial (NCT02477644) reported final survival benefit associated with olaparib plus bevacizumab maintenance treatment of patients with advanced ovarian cancer (AOC) based on molecular status. Our aimed to...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A phase I dose-finding trial of hyperthermic intraperitoneal docetaxel combined with cisplatin in patients with advanced-stage ovarian cancer

You Zy, Wu Mf, Li H, Ye Yf, Wang Lj, Lin Zq, Li J

Objective: To identify the maximum tolerated dose (MTD) of docetaxel combined with a fixed dose of cisplatin (75 mg/m 2 ) delivered as hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with...
Cite
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr